ライフサイエンスコーパス: live birth

1 up to 10% of childhood blindness (~1 in 5000 live birth).

2 considerably reduced (0.13 (0.07-0.21)/1,000 live births).

3 onatal mortality before age 28 days per 1000 live births).

4 d HL was 8 per 11 887 neonates (0.7 per 1000 live births).

5 cts of economic conditions on selection into live birth.

6 ason that archosauromorphs could not achieve live birth.

7 ation on GDM diagnosis was obtained for each live birth.

8 ation, implantation, clinical pregnancy, and live birth.

9 llbirth has a similar immune cell profile to live birth.

10 late into higher probability of pregnancy or live birth.

11 periencing an uncomplicated pregnancy with a live birth.

12 and supported fetal development to term and live birth.

13 this therapy for improving semen quality or live birth.

14 The primary outcome was live birth.

15 results in birth defects, which affect 5% of live births.

16 udal birth defects, which affect 1 in 10 000 live births.

17 of death in infancy, affecting nearly 1% of live births.

18 ue to ARI among infants was 5.02 deaths/1000 live births.

19 ital heart disease (CHD) affects up to 1% of live births.

20 sability in childhood and occurs in 1 in 500 live births.

21 he United States in 2013 was 1.75 per 100000 live births.

22 -child HIV transmission goal of 1 per 100000 live births.

23 ly reported, occurring in at least 1 in 6300 live births.

24 tal disorder affecting approximately 0.8% of live births.

25 dence of GBS-associated NE of 0.019 per 1000 live births.

26 ocephaly occurs in approximately 7 per 10000 live births.

27 articipants ranging between 6,125 and 29,901 live births.

28 Its overall incidence is 1 in 60000 live births.

29 childhood nephropathy, occurring 1 in 20,000 live births.

30 livery among mothers who have had at least 2 live births.

31 ausal women reporting between three and four live births.

32 5.7%), 3 (18.6%), 4 (8.8%), and >/= 5 (5.9%) live births.

33 common birth defect occurring in 1 in 2,500 live births.

34 cavity, with a global incidence of 1 per 700 live births.

35 common birth defect, affecting about 0.8% of live births.

36 contributing to the monthly distribution of live births.

37 affecting approximately one in 10 000 female live births.

38 all neonatal mortality rate was 17 per 1,000 live births.

39 (iv) amniocentesis, and (v) fetal deaths and live births.

40 -weight infants (<1500 g) was 844.1 per 1000 live births.

41 a reported incidence of 1 in 100,000-130,000 live births.

42 1490 completed pregnancies, there were 1431 live births.

43 isorders in humans affecting ~12 per 100 000 live births.

44 gestation, with 218 pregnancies resulting in live births.

45 underwent randomization, and there were 4579 live births.

46 aternal mortality ratio was 36.2 per 100,000 live births.

47 d that due to influenza was 0.07 deaths/1000 live births.

48 mbranes and complicates 5.2% to 28.5% of all live births.

49 of the 5' seed region of the miRNAs produced live births.

50 e risk of pre-eclampsia, but still result in live births.

51 rmation, appearing in approximately 1 in 700 live births.

52 ital virus infection, affecting 0.5 to 2% of live births.

53 ) preterm live-births and 187,966 (9.1%) SGA live-births.

54 Of 1,143 live births, 1,002 were in follow-up at 24 months, and a

55 ene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26-

56 ntation (31%), clinical pregnancy (41%), and live birth (38%).

57 this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9-

58 which have previously been proposed to show live birth(6).

59 iated with 7.9 fewer infant deaths per 1,000 live births (95% CI 3.7, 12.0), reflecting a 13% relativ

60 ted with an increase of 0.07 deaths per 1000 live births (95% CI, 0.01-0.13) the following year.

61 n delivery rate estimates up to 19.1 per 100 live births (95% CI, 16.3 to 21.9) and 19.4 per 100 live

62 rths (95% CI, 16.3 to 21.9) and 19.4 per 100 live births (95% CI, 18.6 to 20.3) were inversely correl

63 ive GBS disease in infants was 0.49 per 1000 live births (95% confidence interval [CI], .43-.56), and

64 overwhelmingly preceded by the evolution of live birth across multiple independent origins of both t

65 The primary outcome was live birth after 24 weeks of gestation.

66 probability of pregnancy (P-trend = 0.83) or live birth after ART (P-trend = 0.47).

67 The primary outcome was live birth after at least 34 weeks of gestation.

68 hazards model was used to investigate first live birth after diagnosis/referent date.

69 programs, 2 years after the first worldwide live birth after uterus transplantation.

70 The incidence of live births after at least 34 weeks of gestation was 75%

71 births before the outbreak and 11 per 10,000 live births after the outbreak.

72 We identified 47,628 live-births after intrauterine insemination (n = 24,962)

73 endometrial cancer and age at first and last live birth, age at menopause, and postmenopausal hormone

74 urpose To compare the probability of a first live birth, age at time of birth, and time between diagn

75 Reproductive factors (number of live births, age at first pregnancy, and total reproduct

76 D including age, pregnancy status, number of live births, age at menarche, menstrual irregularity, ag

77 and positively associated with age at first live birth (all nominal P < 0.05).

78 trates reduced probability of having a first live birth among cancer survivors diagnosed during child

79 erences in the probability of having a first live birth among women diagnosed during adolescence (HR,

80 not result in a significantly higher rate of live births among women with a history of unexplained re

81 Here, we assessed the effect of LDA on male live birth and male offspring, incorporating pregnancy l

82 Whether AH significantly changes live birth and miscarriage rates needs further investiga

83 The impact of IUCT on live birth and postnatal survival was evaluated.

84 uring August 2018, with chart abstraction of live birth and pregnancy information completed during Ap

85 Incidence of pure NHS was 1 in 9500 live births and 1 in 6300 for all forms.

86 Two of the 10 uterus recipients had live births and 3 still had viable grafts.

87 were 21 infants with birth defects among 395 live births and 5 fetuses with birth defects among 47 pr

88 From 1997 to 2014, 970,583 live births and 6510 infant deaths were registered.

89 en with higher AAMRs had significantly fewer live births and a younger ALB.

90 ey and urinary tract are observed in 0.5% of live births and are a major cause of end-stage renal dis

91 Birth defects occur in up to 3% of all live births and are the leading cause of infant death.

92 Edwards syndrome, occurs in about 1 in 6000 live births and causes multiple birth defects in affecte

93 CA occurs in approximately 1/5000 live births and is a frequent component of congenital di

94 a unique 10-digit identifier assigned to all live births and new residents in Denmark.

95 ith progesterone would increase the rates of live births and newborn survival among women with unexpl

96 tion-based cohort study (N=5 901 701) of all live births and stillbirths (including late-pregnancy te

97 on-based retrospective cohort study covering live births and stillbirths among women aged 15 years an

98 rth outcomes surveillance study compared all live births and stillbirths with a gestational age of at

99 infection among infants was 0.26 deaths/100 live births and that due to influenza was 0.07 deaths/10

100 al annual incidence of MNM was 7.2 per 1,000 live births and the intra-hospital maternal mortality ra

101 We test whether cumulative live births and the pace of reproduction are associated

102 Use of ART among all live births and use of certain ART procedures among ART

103 6%) perinatal deaths, 116,043 (5.6%) preterm live-births and 187,966 (9.1%) SGA live-births.

104 meet both the neonatal (12 deaths per 1,000 live births) and under-5 targets simultaneously.

105 up, 149 women became pregnant, 131 women had live births, and 16 women had several pregnancies, resul

106 locardiofacial syndrome) occurs in 1 of 4000 live births, and 60% to 70% of affected individuals have

107 tively associated with smoking and number of live births, and positively associated with age at first

108 tted to ICU, an admission rate of 34.6/1,000 live births, and the mortality index to severe maternal

109 Limitations: The study was based on live births, and the possibility that data on miscarriag

110 and cardiovascular system malformation among live births, and this risk is significantly higher in hi

111 lity rate in Andhra Pradesh was 44 per 1,000 live births, and was higher in the rural areas and triba

112 approximately 1 per 18,800) to 8.38 per 1000 live births (approximately 1 per 120).

113 s disease ranged from 5.33 cases per 100,000 live births (approximately 1 per 18,800) to 8.38 per 100

114 iple gestation but also a lower frequency of live birth, as compared with gonadotropin but not as com

115 efects during the outbreak was 13 per 10,000 live births, as compared with a prevalence of 8 per 10,0

116 The probability of successful pregnancy with live birth at 1 year and 2 years was 24.4% and 36.7%, re

117 Among live births at 22-26 weeks' gestational age in Sweden, 1

118 The study evaluated live births at or after 35 weeks' gestation at 12 facili

119 Population-level analysis of live births before discharge, 1989-2012, was conducted f

120 s compared with a prevalence of 8 per 10,000 live births before the outbreak and 11 per 10,000 live b

121 f cycles resulting in clinical pregnancy and live birth between women in the fourth versus first quar

122 pecific causes of infant deaths in 7,984,366 live births between 2001 and 2012 in England and Wales.

123 y identify U.S. pregnancies that resulted in live births between 2006 and 2017 from 16 data partners.

124 We included 24,381 and 23,307 live births between July 2010 and June 2013 and 7,823 an

125 Primary outcomes were the proportion of live births born small for gestational age (SGA) or pret

126 g one geopolitical population, the U.S. term live births, born to the five groups of the same ethnic

127 elopment target by 2030 (25 deaths per 1,000 live births), but only Rwanda and Tanzania would meet bo

128 rates of 25 or fewer child deaths per 1,000 live births by 2017, and that 58% of child deaths betwee

129 fants with a population incidence of ~2/1000 live births, caused by hypertrophy of the pyloric sphinc

130 From live birth certificates from three states, we constructe

131 95% CI: 0.99, 2.65) times the probability of live birth compared with women in the lowest quartile (<

132 th or selectively terminated cases and 3,972 live-birth controls were enrolled.

133 sed on National Center for Health Statistics live birth data.

134 Current live birth definition and a reporting system that consid

135 Resident live births during 2000 to 2010 were included, and the a

136 early neonatal mortality was 12.7 per 1,000 live births during the control period and 10.1 per 1,000

137 during the control period and 10.1 per 1,000 live births during the intervention period (aOR, 0.89; 9

138 Among the 53704641 live births during the study period, an increase of euro

139 There were 87,501 singleton live births during the year, and 55.8% occurred out-of-h

140 Primary outcome measures include rates of live births, elective terminations, stillbirths, and con

141 tio of less than or equal to 100 per 100 000 live births; estimated minimum need for surgery in the 2

142 er (ET), ET to implantation, implantation to live birth] estimated odds ratios (OR) and 95% confidenc

143 ridged-race, intercensal population data and live birth estimates were used as denominators.

144 lace outside the United States, four or more live births, exposure to secondhand tobacco smoke, and e

145 insecticide-treated nets [ITNs]) leading to live births fell by 37% (33%-41% 95% credible interval [

146 d with oocyte yield, clinical pregnancy, and live birth following ART.

147 rtile were associated with decreased odds of live birth following IUI (adjusted odds ratio = 0.19; 95

148 f cycles resulting in clinical pregnancy and live birth for individual DEHP metabolites.

149 an elevated odds of failing at IVF prior to live birth ([Formula: see text], 95% CI: 0.95, 1.23 for

150 lying the Quest HCV infection rate to annual live births from 2011 to 2014 resulted in an estimated a

151 6 days) and facility delivery among 679,818 live births from 72 countries with Demographic and Healt

152 based cohort study of all recorded singleton live births from January 1, 1996 to December 31, 2015 us

153 This study included 3422 and 3508 singleton live births from the Australian Longitudinal Study on Wo

154 x mothers, with no difference in the rate of live births, gestational age, or small for gestational a

155 analysis was conducted on April 1, 2015, of live births (>/=500 g) from January 1, 2007, to December

156 In total, 29,873 live births had information on breastfeeding among whom

157 g 74,648 (2.8% of all pregnancies) singleton live births had preeclampsia, and 410 women developed ES

158 Live birth has evolved many times independently in verte

159 s Overall, the probability of having a first live birth (hazard ratio [HR]) was significantly lower;

160 As a group, LSDs affect ~1 in 5000 live births; however, each individual storage disease is

161 ratio at birth (SRB; ratio of male to female live births) imbalance in parts of the world over the pa

162 or significantly decreased PTB and increased live birth in a dose-dependent manner.

163 illion years ago) of southwest China showing live birth in archosauromorphs.

164 once daily) did not improve the chance of a live birth in nonthrombophilic women with unexplained re

165 ple included 137,218 women whose most recent live birth in the 5- year period before the survey took

166 Amongst the 7,823 women with a live birth in the year prior to survey in intervention w

167 a complete sex-reversal capable of achieving live birth in these mice.

168 to assemble a panel of approximately 300,000 live births in 20 countries from 2000 to 2008; these obs

169 strict 5q0 declined from 99 deaths per 1,000 live births in 2000 to 70 in 2010.

170 cephalopathy (HIE) occurs in 1 to 8 per 1000 live births in developed countries.

171 prevalence of FASD weighted by the number of live births in each country was estimated.

172 ation-based nested case-control study of all live births in Finland from 1983 to 1998.

173 using nationwide registries of all singleton live births in Finland surviving until 1 year and a with

174 the neonatal mortality (day 0-27) per 1,000 live births in intervention and comparison wards based o

175 More than 25% of live births in low- and middle-income countries are at f

176 ren, is a potential complication for 7.7% of live births in Mexico.

177 live births in singletons and 5.1 per 10,000 live births in multiples.

178 e KIDS Study) enrolled mothers who delivered live births in New York (2008-2010).

179 ficantly higher than 0.36 and 0.72 per 1,000 live births in North Asians and South Asians, respective

180 We selected 4274 singleton live births in our analysis, 315 (7.4%) of which were pr

181 ion, and year of delivery) who had singleton live births in Quebec, Canada (1990-2007).

182 s during the study period was 3.6 per 10,000 live births in singletons and 5.1 per 10,000 live births

183 irth Register (MBR), women who had singleton live births in Sweden between 1982 and 2012, including t

184 41 healthy women who had 2,665,320 singleton live births in Sweden between 1982 and 2012.

185 Follow-up of all live births in Sweden between 1992 and 2005, defined in

186 ased cohort study consisted of all singleton live births in Sweden from January 1, 1982, through Dece

187 July 2010 and June 2013 and 7,823 and 7,555 live births in the last year in intervention and compari

188 iated with a decline of 0.23 deaths per 1000 live births in the same year (95% CI, -0.37 to -0.09) an

189 h outcomes, using natality data on singleton live births in the United States during 1990-2013.

190 ngzhou, China, we included 215,059 singleton live births in the warm season (1 May-31 October) betwee

191 ortality and morbidity, affecting >1% of all live births in the Western world, yet a large fraction o

192 sectional study using maternal data from all live births in women age 15 to 44 years between 2007 and

193 ,000 person-years (or 831 deaths per 100,000 live births) in the first year postpartum.

194 ates of pre-pregnancy hypertension per 1,000 live births increased among both rural (13.7 to 23.7) an

195 ing system that considers a 100 g periviable live birth infant as a neonatal death has placed Ohio an

196 Three hundred forty-nine live birth infants weighed <=500 g and 336 died.

197 However, live birth is unknown in the major clade Archosauromorph

198 equency of preterm births (14.9% among 1,662 live births) is noteworthy.

199 (RTT), which affects approximately 1:10.000 live births, is a X-linked pervasive neuro-developmental

200 uctively unhealthy worker effect (women with live births leave the workforce, while women with nonliv

201 a large sample of pregnancies resulting in a live birth.Materials and MethodsThe Sentinel Distributed

202 th the number of maternal deaths per 100 000 live births (maternal mortality ratio; MMR) in WHO membe

203 10,888 identified articles, 55 (n = 367,801 live births) met the inclusion criteria and were summari

204 3 revision of the US Standard Certificate of Live Birth (N = 17,896,048).

205 ational diabetes mellitus was 318 per 10 000 live births (n=232) in comparison with a baseline risk o

206 Live birth occurred in 98% of pregnancies.

207 Live births occurred in 76% of pregnancies in child-tx m

208 We conducted a population study of all live births occurring in England and Wales between 1 Jan

209 Methods: A total of 160,641 singleton live births occurring in the City of Toronto, Canada bet

210 Exposure: Live birth of an infant with a major congenital anomaly

211 The primary exposure was a live birth of an infant with NAS, and the main outcome w

212 uring pregnancy, 8.8 months), there were 156 live births of 160 infants (4 twin pairs), 1 fetal death

213 the temporal and regional variations in the live births of the UK population, there was a significan

214 for temporal and regional variations in the live births of the UK population.

215 sults were mirrored by DHS results of 73,462 live births (of which 1,360 were twin) indicating that t

216 .1), excluding a 10% increase in the rate of live-birth on enoxaparin (P = .34).

217 % CI 1.10-1.47), types of controls included (live birth OR 2.82 95% CI: 1.64-4.86).

218 63 women with at least 1 pregnancy ending in live birth or stillbirth in Denmark, 1978-2012, with fol

219 A total of 662 live-birth or selectively terminated cases and 3,972 liv

220 ancy or up to 42 days postpartum per 100,000 live births) or neonatal mortality rates (neonatal morta

221 The primary outcomes were adverse live birth outcome (composite of small for gestational a

222 The prevalence of adverse live birth outcome was similar in the ISTp-DP (29.9%) an

223 Live birth outcomes were available for all couples, and

224 per woman less in 2010 and 13 million fewer live births over the 1995-2010 period.

225 nancy hypertension were calculated per 1,000 live births overall and by urbanization status.

226 terus transplant live birth rate (defined as live birth per transplanted recipient).

227 the body, occurs with a frequency of about 2 live births per 100 000 newborns although this incidence

228 g disease (HSCR) is approximately 15/100 000 live births per newborn but has been reported to show si

229 torum was an estimated 0.4 cases per 100 000 live births per year from 2013 to 2017.

230 In Brazil, where there are 3 million live births per year, the application of this definition

231 (n = 4418) to test whether parity (number of live births) predicted four previously-validated composi

232 Sentinel database (2001-2015), we identified live-birth pregnancies conceived through in-vitro fertil

233 A total of 78,150 live-birth pregnancies were identified: 6,872 (8.8%) wer

234 Background - Nearly one in 100 live births presents with congenital heart defects (CHD)

235 ls have PKU, with global prevalence 1:23,930 live births (range 1:4,500 [Italy]-1:125,000 [Japan]).

236 ents), graft survival, and uterus transplant live birth rate (defined as live birth per transplanted

237 potential of preimplantation embryos and the live birth rate, it might represent a novel means to imp

238 going IVF, the cumulative prognosis-adjusted live-birth rate after 6 cycles was 65.3%, with variation

239 In all women, the live-birth rate for the first cycle was 29.5% (95% CI, 2

240 r than 40 years using their own oocytes, the live-birth rate for the first cycle was 32.3% (95% CI, 3

241 The live-birth rate was 37.4% (176 of 470 women) in the levo

242 of 552 women in the water group (28.1%) had live births (rate ratio, 1.38; 95% CI, 1.17 to 1.64; P<0

243 7.8 years of follow-up (risk, 2.13 per 1000 live births; rate, 2.63/10000 child-years).

244 re ART treatment were associated with higher live birth rates among a population exposed to folic aci

245 is translated into an adjusted difference in live birth rates of 26% (95% CI: 10%, 48%; P = 0.02).

246 nificantly improve semen quality or couples' live birth rates.

247 reduce multiple gestations while maintaining live birth rates.

248 ether levothyroxine treatment would increase live-birth rates among euthyroid women who had thyroid p

249 tion of ovarian tissue has led to successful live births, reintroduction of latent malignant cells in

250 tract (CAKUT) occur in three to six of 1000 live births, represent about 20% of the prenatally detec

251 2.3)/1,000 births and 0.76 (0.25-1.77)/1,000 live births, respectively).

252 herited EB were 19.60 and 8.22 per 1 million live births, respectively.

253 y period were 55.2, 30.7, and 23.0 per 1,000 live births, respectively.

254 Overall, 5,707 live-births resulted in an infant with a major malformat

255 The co-primary outcomes were live birth (resulting from pregnancies occurring within

256 mortality rate in Whites was 0.78 per 1,000 live births, significantly higher than 0.36 and 0.72 per

257 cratching did not result in a higher rate of live birth than no intervention among women undergoing I

258 ntibodies did not result in a higher rate of live births than placebo.

259 esult in a significantly higher incidence of live births than placebo.

260 bined with LDA+LMWH was also associated with live births that occurred close to full term in all pati

261 -0.09) and a decline of 0.16 deaths per 1000 live births the following year (95% CI, -0.30 to -0.03).

262 Among 23,118,656 singleton live births, the excess risk of IUGR among Black women,

263 According to national data for live births, the incidence of perinatal HIV infection am

264 evalent birth defect, affecting nearly 1% of live births; the incidence of CHD is up to tenfold highe

265 n hospitals compared to women with singleton live births; this difference was significant in 5 of the

266 Live births to AYA cancer survivors may have an increase

267 0 to December 2014 to identify postdiagnosis live births to AYA survivors (n = 2598).

268 among racial/ethnic minorities for singleton live births to women aged 19 years and older.

269 Among 47,949,381 live births to women between 2007 and 2018, rates of pre

270 .001) and had significantly higher ratios of live-births to miscarriages than women of Mestizo or Eur

271 Twenty-one pregnancies (78%) resulted in a live birth, two preterm infants were stillborn, and four

272 Among the 4854 who had a live birth, vaccinated women were statistically signific

273 The frequency of live birth was 180 of 690 women (26.1%) in the endometri

274 ulation, overall mortality for infants after live birth was 28.2% (267/948).

275 Live birth was not significantly different between treat

276 ere self-reported by women up to 5 y after a live birth was the main limitation.

277 EOS risk per 1000 live births was 1.48; 0.76 in term and 15.52 in preterm

278 Neonatal mortality rate per 1000 live births was 11.4.

279 an intention-to-treat analysis, the rate of live births was 65.8% (262 of 398 women) in the progeste

280 In this nationwide sample of live births we observed no association between induction

281 tsAmong 4 692 744 pregnancies resulting in a live birth, we identified 6879 exposures to GBCAs in 545

282 For live births, we identified 368 (29.3%) discordances betw

283 For 2015 live births, we used a compartmental model to estimate (

284 Biobank age 40 to 69 years who reported >=1 live birth were included.

285 -encapsulated follicles resumed cycling, and live births were achieved only for follicles transplante

286 ternal iliac vessels and removed when 1 or 2 live births were achieved.

287 women with two or more consecutive singleton live births were analysed.

288 Following exclusions, the 12,355,251 live births were classified by birthweight: 500-1,499 g

289 Rates of ongoing pregnancy and live births were higher among women who underwent hyster

290 Overall, 51.3% of the live births were male, and there were 36,485 infant deat

291 Provincial live births were obtained from Statistics Canada.

292 neonatal mortality by 38.3 deaths per 1,000 live births, which corresponds to an increase of around

293 XPECT study 99.1% of pregnancies resulted in live births, which was similar to 99.3% in the QECC.

294 r woman infected with Bundibugyo virus had a live birth with maternal and infant death in Isiro, the

295 Of 214 live births with first-trimester exposure to second-gene

296 ion, in 797 offspring at age 5 y (82% of 973 live births) with the use of the McCarthy Scales of Chil

297 men (mean age = 28 years) reported to have a live birth within the previous two years in the 2014 and

298 A retrospective review of 290992 live births within the Intermountain Healthcare System i

299 CMV infection (cCMVi) affects 0.5-1% of all live births worldwide, making it the leading cause of se

300 Andean women experienced first live-births younger than Mestizo or European women (21.7